The Board has granted service connection for myeloproliferative disorder, finding that the evidence is in equipoise and resolving all doubt in favor of the Veteran. The condition is presumed to be related to exposure to herbicide agents during service.
The deciding factor: The Board found a significant possibility that the Veteran's myeloproliferative disorder was directly related to exposure to herbicide agents in service, given his age, gender, and exposure to chemicals.
- Claimed conditions
- myeloproliferative disorder
- How they argued it
- Reopened with new and material evidence
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- None in this decision
- Decision date
- March 28, 2019
- Citation
- 19123299
Veterans Law Judge
Decisions by this judge: 439 · Granted: 19% (granted or partly granted, in the vetted decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 19123299.
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Veteran's claims for service connection for myeloproliferative disorder and thrombocytopenia, related to in-service radiation exposure during Operation Tomodachi, are being remanded due to the need for a VA examination. The issues of entitlement to a temporary total disability rating due to hospitalization or treatment for a service-connected condition requiring convalescence are also being remanded as they are inextricably intertwined with the service connection claims.
- Remanded (sent back)
The Veteran's claims for service connection of hypertension, migraines, and myeloproliferative disorder are being remanded due to a duty to assist error in obtaining private treatment records. The Board will consider the evidence again after acquiring these records.
- Granted
The Board has granted a 100% disability rating for the Veteran's myeloproliferative disorder, including myelofibrosis and myeloid leukemia, finding that his condition equated with symptoms requiring peripheral blood or bone marrow stem cell transplant, or continuous myelosuppressive or immunosuppressive therapy treatment.
- Remanded (sent back)
The Veteran's claim for service connection for myeloproliferative disorder and renal cell carcinoma is being remanded due to the need for a VA examination to determine the nature and etiology of these conditions, as well as whether they are related to in-service herbicide exposure.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.